Dermavant Sciences GmbH
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://dermavant.com
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 33
- Registration Number
- NCT04103060
- Locations
- 🇺🇸
Dermavant Investigational Site, Worcester, Massachusetts, United States
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 763
- Registration Number
- NCT04053387
- Locations
- 🇨🇦
Dermavant Investigative Site, Montréal, Quebec, Canada
🇨🇦Dermavant Clinical Site, Markham, Ontario, Canada
🇺🇸Dermavant Investigational Site, Detroit, Michigan, United States
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT04042103
- Locations
- 🇺🇸
Dermavant Investigational Site, Spokane, Washington, United States
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
- First Posted Date
- 2019-06-12
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 515
- Registration Number
- NCT03983980
- Locations
- 🇨🇦
Dermavant Investigative Site, Ottawa, Ontario, Canada
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 510
- Registration Number
- NCT03956355
- Locations
- 🇨🇦
Dermavant Investigative Site, Montréal, Quebec, Canada
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT03415282
- Locations
- 🇺🇸
Dermavant Investigational Site, Richmond, Virginia, United States
Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 110
- Registration Number
- NCT03394677
- Locations
- 🇨🇦
Dermavant Investigational Site, Montreal, Quebec, Canada
Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 157
- Registration Number
- NCT02950922
- Locations
- 🇨🇦
Dermavant Investigator Site, Waterloo, Ontario, Canada
🇨🇦Dermavant Investigational Site, Montreal, Quebec, Canada
A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 62
- Registration Number
- NCT02094235
A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 78
- Registration Number
- NCT01461941
© Copyright 2024. All Rights Reserved by MedPath